The new service chief will report to the Deputy Division Head of Cellular Therapy and the Head of DHM, and will have programmatic oversight and responsibility for the service and faculty. This service will operate in a matrix reporting structure, with providers practicing in disease specific services, along with the Cellular Therapy Service. The service chief will work to shape the strategic and programmatic priorities for the service, clinical excellence, clinical operational efficiency, talent acquisition and retention, research, grant funding, professional development, mentorship and teaching. The administrative infrastructure available in the service will allow the service chief to maintain both a clinical practice and an independent research program.
At a minimum, qualified candidates should be/should have an:
Nationally recognized clinician as well as a leader in clinical, translational, laboratory based or population science
Extensive knowledge of the clinical care of patients with Immune Effector Cells, with experience in both Hematologic Malignancy and Solid Tumor care.
Board-eligible or board-certified in Medical Oncology and/or Hematology
Eligible for licensure in New York State and New Jersey
MSK has a strong commitment to enhancing the diversity of its faculty and staff. Applicants from diverse racial, ethnic, and cultural backgrounds are encouraged to apply. MSK offers competitive salaries and benefits. Interested applicants should send curriculum vitae and letter of interest to Valentina Salkow at firstname.lastname@example.org and Monchell Johnson at email@example.com
Internal Number: 2020-45467
About Memorial Sloan-Kettering Cancer Center
As one of the world's premier cancer centers, Memorial Sloan-Kettering Cancer Center is committed to exceptional patient care, leading-edge research, and superb educational programs. The close collaboration between our physicians and scientists is one of our unique strengths, enabling us to provide patients with the best care available today as we work to discover more effective strategies to prevent, control, and ultimately cure cancer in the future. Our education programs train future physicians and scientists, and the knowledge and experience they gain at Memorial Sloan-Kettering has an impact on cancer treatment and the biomedical research agenda around the world.